{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:33:46Z","timestamp":1784010826433,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["K12"],"award-info":[{"award-number":["K12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12905-019-0766-6","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:03:39Z","timestamp":1559034219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Joshua","family":"Dean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fauzia","family":"Akbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaunte","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"H\u00fcttemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay M.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-3962","authenticated-orcid":false,"given":"Maurice-Andre","family":"Recanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"766_CR1","unstructured":"Fahs B, McClelland S. When Sex and Power Collide: An Argument for Critical Sexuality Studies2016. 1\u201325 p."},{"issue":"4","key":"766_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.21859\/ijtmgh-040405","volume":"4","author":"W Dandehbor","year":"2016","unstructured":"Dandehbor W, Kazemi M, Salehi Shahrbabaki MH, Ghorashi Z, Sadrmohammad R, Bozorg B, et al. Menstrual suppression using Oral contraceptives by female hajj pilgrims. International Journal of Travel Medicine and Global Health. 2016;4(4):111\u20134.","journal-title":"International Journal of Travel Medicine and Global Health"},{"issue":"4","key":"766_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/jfprhc-2012-100401","volume":"38","author":"A Mohammed-Durosinlorun","year":"2012","unstructured":"Mohammed-Durosinlorun A, Raji HO, Hussain NA, Badmus SA, Ijaiya MA. Menstrual suppression among female Nigerian pilgrims during hajj. The journal of family planning and reproductive health care. 2012;38(4):270\u20131.","journal-title":"The journal of family planning and reproductive health care"},{"issue":"6","key":"766_CR4","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.fertnstert.2006.05.050","volume":"86","author":"Y Yairi-Oron","year":"2006","unstructured":"Yairi-Oron Y, Rabinson J, Orvieto R. A simplified approach to religious infertility. Fertil Steril. 2006;86(6):1771\u20132.","journal-title":"Fertil Steril"},{"key":"766_CR5","doi-asserted-by":"crossref","unstructured":"Ganzel T, Zimmerman D. Hormonal Intervention for Religious Concerns: A Halakhic and Ethical Discussion2011. p. 114\u201329.","DOI":"10.2979\/nashim.21.114"},{"key":"766_CR6","first-page":"1","volume-title":"The Jewish Bride: Getting to Her Wedding Night Ritually Clean Using Norethindrone Acetate (Aygestin \u00ae)","author":"MM Grajower","year":"2009","unstructured":"Grajower MM, Willig RM, Grazi R. The Jewish Bride: Getting to Her Wedding Night Ritually Clean Using Norethindrone Acetate (Aygestin \u00ae); 2009. p. 1\u20138."},{"issue":"8","key":"766_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1089\/jwh.2007.0332","volume":"16","author":"K Lin","year":"2007","unstructured":"Lin K, Barnhart K. The clinical rationale for menses-free contraception. Journal of women's health (2002). 2007;16(8):1171\u201380.","journal-title":"Journal of women's health (2002)"},{"key":"766_CR8","first-page":"43","volume":"7","author":"J Villavicencio","year":"2016","unstructured":"Villavicencio J, Allen RH. Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates. Open Access J Contracept. 2016;7:43\u201352.","journal-title":"Open Access J Contracept"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"b2895","DOI":"10.1136\/bmj.b2895","volume":"339","author":"JJ Amy","year":"2009","unstructured":"Amy JJ, Tripathi V. Contraception for women: an evidence based overview. BMJ (Clinical research ed). 2009;339:b2895.","journal-title":"BMJ (Clinical research ed)"},{"issue":"15","key":"766_CR10","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMcp030751","volume":"349","author":"DB Petitti","year":"2003","unstructured":"Petitti DB. Clinical practice. Combination estrogen-progestin oral contraceptives. N Engl J Med. 2003;349(15):1443\u201350.","journal-title":"N Engl J Med"},{"issue":"3","key":"766_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports. 2016;65(3):1\u2013103.","journal-title":"MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports"},{"issue":"3","key":"766_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.contraception.2015.05.006","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Phillips SJ, Kapp N, Gaffield ME, Curtis KM. Combined hormonal contraceptive use among breastfeeding women: an updated systematic review. Contraception. 2016;94(3):262\u201374.","journal-title":"Contraception."},{"issue":"2","key":"766_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","volume":"68","author":"FD Anderson","year":"2003","unstructured":"Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception. 2003;68(2):89\u201396.","journal-title":"Contraception."},{"issue":"6","key":"766_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1745-7599.2004.tb00444.x","volume":"16","author":"S Freeman","year":"2004","unstructured":"Freeman S. Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling. J Am Acad Nurse Pract. 2004;16(6):226\u201338.","journal-title":"J Am Acad Nurse Pract"},{"issue":"3","key":"766_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","volume":"112","author":"PJ Sulak","year":"2008","unstructured":"Sulak PJ, Smith V, Coffee A, Witt I, Kuehl AL, Kuehl TJ. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial. Obstet Gynecol. 2008;112(3):563\u201371.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"766_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","volume":"106","author":"L Miller","year":"2005","unstructured":"Miller L, Verhoeven CH, Hout J. Extended regimens of the contraceptive vaginal ring: a randomized trial. Obstet Gynecol. 2005;106(3):473\u201382.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"766_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1056\/NEJMoa1204724","volume":"368","author":"J Gupta","year":"2013","unstructured":"Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368(2):128\u201337.","journal-title":"N Engl J Med"},{"key":"766_CR18","first-page":"777","volume":"7","author":"AM Attia","year":"2013","unstructured":"Attia AM, Ibrahim MM, Abou-Setta AM. Role of the levonorgestrel intrauterine system in effective contraception. Patient preference and adherence. 2013;7:777\u201385.","journal-title":"Patient preference and adherence"},{"key":"766_CR19","volume-title":"Clinical gynecologic endocrinology and infertility","author":"L Speroff","year":"1989","unstructured":"Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1989.","edition":"4"},{"issue":"6 Suppl","key":"766_CR20","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.contraception.2007.01.020","volume":"75","author":"ME Ortiz","year":"2007","unstructured":"Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007;75(6 Suppl):S16\u201330.","journal-title":"Contraception."},{"issue":"2","key":"766_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","volume":"65","author":"M Hidalgo","year":"2002","unstructured":"Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years<sup>1<\/sup>. Contraception. 2002;65(2):129\u201332.","journal-title":"Contraception."},{"issue":"1","key":"766_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","volume":"70","author":"J Jain","year":"2004","unstructured":"Jain J, Dutton C, Nicosia A, Wajszczuk C, Bode FR, Mishell DR Jr. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of depo-Provera. Contraception. 2004;70(1):11\u20138.","journal-title":"Contraception."},{"key":"766_CR23","first-page":"1","volume-title":"Depot-medroxyprogesterone acetate: An update","author":"S Bakry","year":"2008","unstructured":"Bakry S, Merhi ZO, Scalise TJ, Mahmoud M, Fadiel A, Naftolin F. Depot-medroxyprogesterone acetate: An update; 2008. p. 1\u201312."},{"issue":"3","key":"766_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","volume":"74","author":"RD Arias","year":"2006","unstructured":"Arias RD, Jain JK, Brucker C, Ross D, Ray A. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception. 2006;74(3):234\u20138.","journal-title":"Contraception."},{"issue":"2","key":"766_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S0021932000007938","volume":"3","author":"EB McDaniel","year":"1971","unstructured":"McDaniel EB, Pardthaisong T. Return of menstruation and fertility in Thai women after contraceptive injections. J Biosoc Sci. 1971;3(2):209\u201322.","journal-title":"J Biosoc Sci"},{"issue":"5","key":"766_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0010-7824(73)90163-7","volume":"8","author":"EB McDaniel","year":"1973","unstructured":"McDaniel EB, Pardthaisong T. Depot-medroxyprogesterone acetate as a contraceptive agent: return of fertility after discontinuation of use. Contraception. 1973;8(5):407\u201314.","journal-title":"Contraception."},{"issue":"6","key":"766_CR27","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/humrep\/den091","volume":"23","author":"I Mavranezouli","year":"2008","unstructured":"Mavranezouli I. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for health and clinical excellence (NICE) clinical practice guideline. Hum Reprod. 2008;23(6):1338\u201345.","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"766_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13625180801959931","volume":"13","author":"D Mansour","year":"2008","unstructured":"Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception. 2008;13(Suppl 1):13\u201328.","journal-title":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception"},{"issue":"1","key":"766_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.13181\/mji.v8i1.950","volume":"8","author":"B Affandi","year":"1999","unstructured":"Affandi B. Pregnancy after removal of Etonogestrel implant contraceptive (Implanon \u00ae). Med J Indones. 1999;8(1):62\u20134.","journal-title":"Med J Indones"},{"issue":"4","key":"766_CR30","first-page":"207","volume":"40","author":"HF Taitel","year":"1995","unstructured":"Taitel HF, Kafrissen ME. Norethindrone--a review of therapeutic applications. Int J Fertil Menopausal Stud. 1995;40(4):207\u201323.","journal-title":"Int J Fertil Menopausal Stud"},{"key":"766_CR31","first-page":"704","volume-title":"Modern pharmacology with clinical applications","author":"JS Strobl","year":"2003","unstructured":"Strobl JS. Estrogens, Progestins, and specific estrogen receptor modulators (SERMs). In: Craig CR, Stitzel RE, editors. Modern pharmacology with clinical applications. 6th ed. London: Lippincott Williams & Wilkins; 2003. p. 704\u20139.","edition":"6"},{"issue":"3","key":"766_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0010-7824(91)90014-7","volume":"44","author":"MJ Ball","year":"1991","unstructured":"Ball MJ, Ashwell E, Gillmer MDG. Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone. Contraception. 1991;44(3):223\u201333.","journal-title":"Contraception."},{"issue":"5","key":"766_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0010-7824(90)90077-9","volume":"42","author":"M Broome","year":"1990","unstructured":"Broome M, Fotherby K. Clinical experience with the progestogen-only pill. Contraception. 1990;42(5):489\u201395.","journal-title":"Contraception."},{"key":"766_CR34","doi-asserted-by":"crossref","unstructured":"Grimes DA, Lopez LM, O'Brien PA, Raymond EG. Progestin-only pills for contraception. The Cochrane database of systematic reviews. 2013;11 Cd007541.","DOI":"10.1002\/14651858.CD007541.pub3"},{"issue":"6","key":"766_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jpag.2015.05.005","volume":"28","author":"JE Dietrich","year":"2015","unstructured":"Dietrich JE, Srivaths L. Navigating hormones and gynecologic concerns among female adolescents in the settings of thrombophilia and anticoagulation. J Pediatr Adolesc Gynecol. 2015;28(6):549\u201353.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"766_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0010-7824(82)90105-6","volume":"26","author":"IS Fraser","year":"1982","unstructured":"Fraser IS, Weisberg E. Fertility following discontinuation of different methods of fertility control. Contraception. 1982;26(4):389\u2013415.","journal-title":"Contraception."},{"issue":"12","key":"766_CR37","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jama.1958.62990120001011","volume":"166","author":"RB Greenblatt","year":"1958","unstructured":"Greenblatt RB, Jungck EC. Delay of menstruation with norethindrone, an orally given progestational compound. J Am Med Assoc. 1958;166(12):1461\u20133.","journal-title":"J Am Med Assoc"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-019-0766-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-019-0766-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-019-0766-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:07:37Z","timestamp":1590534457000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-019-0766-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s12905-019-0766-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"23 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board at St. Vincent\u2019s Catholic Medical Centers Manhattan, (IRB#040818\u2009M1), ClinicalTrials.gov identifier NCT03594604, and written informed consent was obtained from each patient. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors report any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"70"}}